Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco blog main
4
×
biotech
deals
national top stories
new york blog main
san diego blog main
startups
boston blog main
cancer
eli lilly
fda
ipo
national
san diego top stories
san francisco top stories
vc
wisconsin blog main
wisconsin top stories
4490 ventures
abaloparatide
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
agro biosciences
agtech products
agtechfood
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
amgen
apalutamide
apps
arm & hammer animal nutrition
armo biosciences
atypical hemolytic uremic syndrome
What
raise
4
×
drug
advance
alzheimer’s
amgen
amgen’s
approval
bigger
bio
biology
carries
companies
company
cytokine
deals
developed
different
drugs
enhanced
europe
european
exits
fail
files
founders
funding
gene
health's
healthcare
heart
increases
initial
initially
investors
ipo
latest
laying
marketing
medicine
money
Language
unset
Current search:
raise
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
